• Login
    View Item 
    •   DSpace Home
    • INVESTIGACIÓN
    • Artículos SCOPUS
    • View Item
    •   DSpace Home
    • INVESTIGACIÓN
    • Artículos SCOPUS
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    El Repositorio Institucional de la Universidad Mayor, tiene como objetivo publicar, en formato digital, todos los objetos derivados de su producción científica, académica, cultural y artística. En palabras simples es una vitrina que pone en valor su patrimonio documental.


    InformaciónInicioAcerca deFormulariosManuales

    Browse

    All of DSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    xmlui.EPerson.Navigation.loginxmlui.EPerson.Navigation.register

    Rendimiento diagnóstico de la detección de células prostáticas malignas en la circulación sanguínea para la detección precoz de cáncer prostático: Una comparación con la biopsia prostática

    Thumbnail
    Date
    2011
    Author

    Murray, Nigel P. [Chile. Universidad Mayor. Facultad de Medicina]

    Reyes, Eduardo [Hospital de Carabineros de Chile]

    Tapia, Pablo [Hospital de Carabineros de Chile]

    Orellana, Nelson [Hospital de Carabineros de Chile]

    Dueñas, Ricardo R. [Hospital de Carabineros de Chile]

    Fuentealba, Chyntia [Hospital de Carabineros de Chile]

    Badinez, Leonardo V. [Chile. Fundación Oncológica Arturo López Pérez]

    Geographic location

    Note
    Tools
    Cite
    Vea como citar este artículo

    Show full item record
    Abstract
    OBJECTIVES: Serum prostate specific antigen and digital rectal examination are the tests used as screening tests to detect prostate cancer. However, only approximately 30% of men with suspicion of cancer have it confirmed on prostate biopsy, and not all of these need treatment. Detection of circulating tumor cells in localized prostate cancer has given variable results, but it could be a useful complementary screening tool to detect prostate cancer in men with abnormal screening tests before the evaluation with prostate biopsy. To evaluate the diagnostic yield of the detection of mCPC as a complementary PC screening test in a population fulfilling criteria for a prostate biopsy for suspicion of PC. METHODS: A prospective screening study of consecutive patients aged 45-80 years presenting to the urologist for PC screening. Inclusion criteria were PSA >4.0 ng/ml, PSA velocity >0.35 ng/ml/year and/or DRE suspicious for cancer. Patients fulfilling inclusion criteria had blood taken for mCPC detection and then underwent 12-core transrectal prostate biopsy. Double immune-histochemical staining with anti-PSA and anti-P504S was used to detect mCPC. Both cytologist and pathologist were blinded to the results of the biopsy, mCPC results and clinical details. The diagnostic yield of the presence or absence of mCPC was evaluated; the prostate biopsy was classified as cancer or no -cancer. RESULTS: 228 men participated, with a mean age of 66.8 ± 8.8 years and a median serum PSA of 5.15 ng/ml. 28.6% of the biopsies were positive for PC, and mCPC were detected in 31.0%of all cases. Sensibility, specificity and negative predictive value were 86.2%, 90.8% and 94.3% respectively. The negative and positive like-lihood ratios were 9.36 and 0.15. In men with a PSA <4.0ngml, 13.3% had cancer detected on biopsy, with a sensibility and specificity for mCPC detection of 83.3% and 84.6% and negative predictive value of 97.1%. All the mCPC determinations were interpretable. There were 9 false negative cases, all with small low grade tumors. CONCLUSIONS: The use of mCPC detection could be useful as a complementary prostate cancer screening test, especially for excluding cancer, including patients with a serum PSA <4.0 ng/ml.
    URI
    https://www.redalyc.org/articulo.oa?id=181022517009
    http://repositorio.umayor.cl/xmlui/handle/sibum/2590
    Collections
    • Artículos SCOPUS

    Si usted es autor(a) de este documento y NO desea que su publicación tenga acceso público en este repositorio, por favor complete el formulario aquí.

    Related items

    Showing items related by title, author, creator and subject.

    • Concordancia entre histología pre, intra y postoperatoria en cáncer de endometrio 

      Serman V., Felipe [Hospital de Carabineros de Chile]; Sánchez A., María Elena [Hospital de Carabineros de Chile]; Barrientos F., Bárbara [Hospital de Carabineros de Chile]; Saldaña G., Bárbara [Hospital de Carabineros de Chile]; Trullen S., Javier [Chile. Universidad Mayor]; Burky A., Daniela [Chile. Universidad Mayor]; Calvo S., Paula [Chile. Universidad Mayor]; Matus I., Maritza [Hospital de Carabineros de Chile]; Walton L., Roderick [Universidad de Santiago de Chile] (Facultad de Ciencias, 2012)
      Antecedentes: En pacientes con cáncer de endometrio se discute la concordancia entre biopsia pre e intraoperatoria versus la definitiva, en grado de diferenciación, tipo histológico y profundidad de mioinvasión. Método: ...
    • Circulating prostate cells found in men with benign prostate disease are P504S negative: Clinical implications 

      Murray, Nigel P. [Chile. Universidad Mayor. Facultad de Medicina]; Reyes, Eduardo [Hospital de Carabineros de Chile]; Badinez, Leonardo V. [Chile. Fundación Oncológica Arturo López Pérez]; Orellana, Nelson [Hospital de Carabineros de Chile]; Fuentealba, Chyntia [Hospital de Carabineros de Chile]; Olivares, R. [Hospital de Carabineros de Chile]; Porcell, J. [Hospital de Carabineros de Chile] (Facultad de Ciencias, 2013)
      Introduction. Developments in immunological and quantitative real-time PCR-based analysis have enabled the detection, enumeration, and characterization of circulating tumor cells (CTCs). It is assumed that the detection ...
    • Effect of androgen blockade on her-2 and matrix metalloproteinase-2 expression on bone marrow micrometastasis and stromal cells in men with prostate cancer 

      Murray, Nigel P. [Chile. Universidad Mayor. Facultad de Medicina]; Reyes, Eduardo [Hospital de Carabineros de Chile]; Badinez, Leonardo V. [Chile. Fundación Oncológica Arturo López Pérez]; Orellana, Nelson [Hospital de Carabineros de Chile]; Fuentealba, Chyntia [Hospital de Carabineros de Chile]; Olivares, R. [Hospital de Carabineros de Chile]; Porcell, J. [Hospital de Carabineros de Chile] (Facultad de Ciencias, 2013)
      INTRODUCTION: HER-2 has been associated with castrate resistant prostate cancer and matrix metalloproteinase-2 (MMP-2) in the dissemination and invasion of tumor cells as well as activating angiogenesis. We present an ...


    Contact Us | Send Feedback
    Modificado por: Sistema de Bibliotecas Universidad Mayor - SIBUM
    DSpace software copyright © 2002-2018  DuraSpace
     

     



    Contact Us | Send Feedback
    Modificado por: Sistema de Bibliotecas Universidad Mayor - SIBUM
    DSpace software copyright © 2002-2018  DuraSpace